Hybrid solutions
Hybrid solutions: Full service where you need it. FSP where you don’t.
We deploy FSP teams for the parts you want to keep close and run full-service clinical development for the rest, under one governance model and with one partner.
60,000+
active professional profiles for embedded roles
40+
countries for full-service delivery
5
therapeutic areas with deep specialist teams
One programme, two delivery models, one partner
What we run as full service
Whole studies or study components where you want TFS to own delivery: study design, start-up, monitoring, data management, biostatistics and reporting.
What we embed as FSP
Functions you want to keep close to your own team: monitoring, safety, biometrics, regulatory affairs or medical writing, line-managed by TFS inside your organisation.
Built for your exact clinical scenario
Your clinical operations team is strong, but biometrics is stretched
You keep running your studies. We embed an FSP biometrics team to support them, and take on a new study in full service when your team is at capacity.
You are adding an indication outside your in-house expertise
We run the new study as full service with our therapeutic specialists, while FSP teams keep supporting your existing programmes.
You are bringing outsourced work back in house, or the reverse
We run both models side by side during the transition, so you change your operating model without pausing a study.
Built-in flexibility across every model
Show us your programme. We will show you where each model fits.
Securing the path for sponsors’ science.
How modern technology is redefining Phase I–III trial
Global presence designed for local agility
International scale, deep local roots
We have built our structure by integrating established clinical teams across key markets, rather than handing off trials to unknown third parties. Operating directly on the ground allows us to navigate local regulations, streamline ethics approvals and keep recruitment on track.
